Aurobindo Pharma sets up arm in Indonesia for manufacturing
Aurobindo Pharma has incorporated a new subsidiary, PT Auro Pharm Indonesia, to establish manufacturing operations in Indonesia. This move is part of the company's strategy to expand its international production footprint.
Why it matters
The expansion indicates the company's growth strategy and its effort to diversify manufacturing capabilities in Southeast Asia.
Drugmaker Aurobindo Pharma on Friday (July 10, 2026) announced the incorporation of a new subsidiary in Indonesia with plans to undertake manufacturing operations there.
Wholly owned stepdown subsidiary PT Aurogen Pharma Indonesia has incorporated the new company PT Auro Pharm Indonesia and the authorities have approved the same on July 9. The objective is to undertake manufacturing operations in Indonesia, Aurobindo Pharma said in a filing.
Terms & conditions | Institutional Subscriber
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in